Ptc Therapeutics (PTCT) Operating Margin Growth (3y) (2015 - 2026)
Ptc Therapeutics (PTCT) Operating Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ptc Therapeutics | 6.47 Bn | 4.58 Bn | 244.52 Mn | 6,986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,986.00 |
| Dec 31, 2025 | 7,634.00 |
| Sep 30, 2025 | 3,283.00 |
| Jun 30, 2025 | 3,626.00 |
| Mar 31, 2025 | 14,067.00 |
| Dec 31, 2024 | -2,490.00 |
| Sep 30, 2024 | 3,939.00 |
| Mar 31, 2024 | 6,159.00 |
| Dec 31, 2023 | 9,175.00 |
| Sep 30, 2023 | -1,355.00 |
| Jun 30, 2023 | 15,090.00 |
| Mar 31, 2023 | 8,286.00 |
| Dec 31, 2022 | -3,026.00 |
| Sep 30, 2022 | 5,333.00 |
| Jun 30, 2022 | 8.42 Mn |
| Mar 31, 2022 | 7,215.00 |
| Dec 31, 2021 | 131.00 |
| Sep 30, 2021 | 2,388.00 |
| Jun 30, 2021 | 88,836.00 |
| Mar 31, 2021 | -5,331.00 |